Johnny Y. Nagasawa

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Farnesoid X receptor agonists and uses thereof
- Patent number 11,236,071
- Issue date Feb 1, 2022
- METACRINE, INC.
- Nicholas D. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Farnesoid X receptor agonists and uses thereof
- Patent number 11,214,538
- Issue date Jan 4, 2022
- METACRINE, INC.
- Nicholas D. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Farnesoid X receptor agonists and uses thereof
- Patent number 10,961,198
- Issue date Mar 30, 2021
- METACRINE, INC.
- Nicholas D. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Farnesoid X receptor agonists and uses thereof
- Patent number 10,927,082
- Issue date Feb 23, 2021
- METACRINE, INC.
- Nicholas D. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Farnesoid X receptor agonists and uses thereof
- Patent number 10,703,712
- Issue date Jul 7, 2020
- METACRINE, INC.
- Nicholas D. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Farnesoid X receptor agonists and uses thereof
- Patent number 10,626,081
- Issue date Apr 21, 2020
- METACRINE, INC.
- Nicholas D. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic estrogen receptor modulators and uses thereof
- Patent number 10,053,451
- Issue date Aug 21, 2018
- Genentech, Inc.
- Sharada Labadie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Estrogen receptor modulators and uses thereof
- Patent number 9,868,704
- Issue date Jan 16, 2018
- Genentech, Inc.
- Nicholas D. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Estrogen receptor modulators and uses thereof
- Patent number 9,845,291
- Issue date Dec 19, 2017
- Genentech, Inc.
- Jun Liang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Estrogen receptor modulators and uses thereof
- Patent number 9,499,538
- Issue date Nov 22, 2016
- Seragon Pharmaceuticals, Inc.
- Nicholas D. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Estrogen receptor modulators and uses thereof
- Patent number 9,399,646
- Issue date Jul 26, 2016
- Genentech, Inc.
- Nicholas D. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fluorinated estrogen receptor modulators and uses thereof
- Patent number 9,193,714
- Issue date Nov 24, 2015
- Seragon Pharmaceuticals, Inc.
- Nicholas D. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Estrogen receptor modulators and uses thereof
- Patent number 9,187,460
- Issue date Nov 17, 2015
- Seragon Pharmaceuticals, Inc.
- Nicholas D. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Estrogen receptor modulators and uses thereof
- Patent number 9,078,871
- Issue date Jul 14, 2015
- Seragon Pharmaceuticals, Inc.
- Mehmet Kahraman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinolone analogs and methods related thereto
- Patent number 8,853,234
- Issue date Oct 7, 2014
- Senhwa Biosciences, Inc.
- Johnny Yasuo Nagasawa
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Estrogen receptor modulators and uses thereof
- Patent number 8,703,810
- Issue date Apr 22, 2014
- Seragon Pharmaceuticals, Inc.
- Mehmet Kahraman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Estrogen receptor modulators and uses thereof
- Patent number 8,455,534
- Issue date Jun 4, 2013
- Aragon Pharmaceuticals, Inc.
- Nicholas D. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Estrogen receptor modulators and uses thereof
- Patent number 8,299,112
- Issue date Oct 30, 2012
- Aragon Pharmaceuticals, Inc.
- Nicholas D. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protein kinase modulators
- Patent number 8,168,651
- Issue date May 1, 2012
- Cylene Pharmaceuticals, Inc.
- Peter C. Chua
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxindole compounds
- Patent number 8,124,649
- Issue date Feb 28, 2012
- Cylene Pharmaceuticals, Inc.
- Mustapha Haddach
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of Akt activity
- Patent number 8,003,643
- Issue date Aug 23, 2011
- Merck Sharp & Dohme Corp.
- Mark T. Bilodeau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinolone analogs and methods related thereto
- Patent number 7,928,100
- Issue date Apr 19, 2011
- Cylene Pharmaceuticals, Inc.
- Johnny Yasuo Nagasawa
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of preparing quinolone analogs
- Patent number 7,834,180
- Issue date Nov 16, 2010
- Cylene Pharmaceuticals, Inc.
- Peter C. Chua
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of preparing quinolone analogs
- Patent number 7,816,524
- Issue date Oct 19, 2010
- Cylene Pharmaceuticals, Inc.
- Peter C. Chua
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinolone analogs
- Patent number 7,816,406
- Issue date Oct 19, 2010
- Cylene Pharmaceuticals, Inc.
- Jeffrey P. Whitten
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of Akt activity
- Patent number 7,655,649
- Issue date Feb 2, 2010
- Merck Sharp & Dohme Corp.
- Mark T. Bilodeau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulators of the glucocorticoid receptor and method
- Patent number 7,235,662
- Issue date Jun 26, 2007
- Bristol-Myers Squibb Company
- Sara Sabine Hadida-Ruah
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
HSD17B13 INHIBITORS AND USES THEREOF
- Publication number 20240368127
- Publication date Nov 7, 2024
- FL2022-001, Inc.
- Johnny Y. Nagasawa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HSD17B13 INHIBITORS AND USES THEREOF
- Publication number 20240083861
- Publication date Mar 14, 2024
- FL2022-001, Inc.
- Andrew R. Hudson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HSD17B13 INHIBITORS AND USES THEREOF
- Publication number 20240034736
- Publication date Feb 1, 2024
- FL2022-001, Inc.
- Andrew R. Hudson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20220089575
- Publication date Mar 24, 2022
- Metacrine, Inc.
- Nicholas D. SMITH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20220081390
- Publication date Mar 17, 2022
- Metacrine, Inc.
- Nicholas D. SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20220056019
- Publication date Feb 24, 2022
- Metacrine, Inc.
- Nicholas D. SMITH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SSAO INHIBITORS AND USES THEREOF
- Publication number 20220002309
- Publication date Jan 6, 2022
- Metacrine, Inc.
- Nicholas D. SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20210300875
- Publication date Sep 30, 2021
- Metacrine, Inc.
- Nicholas D. SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20210032195
- Publication date Feb 4, 2021
- Metacrine, Inc.
- Nicholas D. SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20200290973
- Publication date Sep 17, 2020
- Metacrine, Inc.
- Nicholas D. SMITH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SSAO INHIBITORS AND USES THEREOF
- Publication number 20200181104
- Publication date Jun 11, 2020
- Metacrine, Inc.
- Nicholas D. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20200131129
- Publication date Apr 30, 2020
- Metacrine, Inc.
- Nicholas D. SMITH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20200131142
- Publication date Apr 30, 2020
- Metacrine, Inc.
- Nicholas D. SMITH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20200131132
- Publication date Apr 30, 2020
- Metacrine, Inc.
- Nicholas D. SMITH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20200131134
- Publication date Apr 30, 2020
- Metacrine, Inc.
- Nicholas D. SMITH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20180282263
- Publication date Oct 4, 2018
- Metacrine, Inc.
- Nicholas D. SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20180244606
- Publication date Aug 30, 2018
- Metacrine, Inc.
- Nicholas D. SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20170197915
- Publication date Jul 13, 2017
- Genentech, Inc.
- Jun Liang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20160347742
- Publication date Dec 1, 2016
- Genentech, Inc.
- Sharada Labadie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20160304450
- Publication date Oct 20, 2016
- Genentech, Inc.
- Jun Liang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20160297767
- Publication date Oct 13, 2016
- Genentech, Inc.
- Nicholas D. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20160175284
- Publication date Jun 23, 2016
- Genentech, Inc.
- Sharada Labadie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20150105403
- Publication date Apr 16, 2015
- SERAGON PHARMACEUTICALS, INC.
- Nicholas D. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FLUORINATED ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20150005286
- Publication date Jan 1, 2015
- SERAGON PHARMACEUTICALS, INC.
- Nicholas D. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20140364427
- Publication date Dec 11, 2014
- Nicholas D. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20140107095
- Publication date Apr 17, 2014
- SERAGON PHARMACEUTICALS, INC.
- Mehmet Kahraman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20130231333
- Publication date Sep 5, 2013
- Aragon Pharmaceuticals, Inc.
- Nicholas D. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20130116232
- Publication date May 9, 2013
- Aragon Pharmaceuticals, Inc.
- Mehmet Kahraman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
- Publication number 20130012561
- Publication date Jan 10, 2013
- Aragon Pharmaceuticals, Inc.
- Nicholas D. SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEIN KINASE MODULATORS
- Publication number 20120208792
- Publication date Aug 16, 2012
- Cylene Pharmaceuticals, Inc.
- Peter C. Chua
- C07 - ORGANIC CHEMISTRY

Johnny Y. Nagasawa

Person

Patents Grantslast 30 patents

Farnesoid X receptor agonists and uses thereof

Farnesoid X receptor agonists and uses thereof

Farnesoid X receptor agonists and uses thereof

Farnesoid X receptor agonists and uses thereof

Farnesoid X receptor agonists and uses thereof

Farnesoid X receptor agonists and uses thereof

Heterocyclic estrogen receptor modulators and uses thereof

Estrogen receptor modulators and uses thereof

Estrogen receptor modulators and uses thereof

Estrogen receptor modulators and uses thereof

Estrogen receptor modulators and uses thereof

Fluorinated estrogen receptor modulators and uses thereof

Estrogen receptor modulators and uses thereof

Estrogen receptor modulators and uses thereof

Quinolone analogs and methods related thereto

Estrogen receptor modulators and uses thereof

Estrogen receptor modulators and uses thereof

Estrogen receptor modulators and uses thereof

Protein kinase modulators

Oxindole compounds

Inhibitors of Akt activity

Quinolone analogs and methods related thereto

Methods of preparing quinolone analogs

Methods of preparing quinolone analogs

Quinolone analogs

Inhibitors of Akt activity

Modulators of the glucocorticoid receptor and method

Patents Applicationslast 30 patents

HSD17B13 INHIBITORS AND USES THEREOF

HSD17B13 INHIBITORS AND USES THEREOF

HSD17B13 INHIBITORS AND USES THEREOF

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

SSAO INHIBITORS AND USES THEREOF

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

SSAO INHIBITORS AND USES THEREOF

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

HETEROCYCLIC ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

FLUORINATED ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

PROTEIN KINASE MODULATORS